| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.04 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.04 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.06 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.065 | 0.06 |